Subscribe free

HPB & Spleen ·

New Hepatocellular Carcinoma Treatment Framework

A new consensus framework for hepatocellular carcinoma (HCC) could transform surgical decision-making and patient outcomes.

  • The BEACON-HCC system integrates clinical features like tumor burden and vascular invasion for more precise treatment options.
  • In a pilot with 29 cases, expert decisions matched BEACON-HCC recommendations 96.6% of the time, compared to 72.4% for current standards.

This framework aligns treatment with tumor biology, paving the way for expanded therapeutic strategies in North America.

  • It includes emerging modalities like external beam radiation therapy and transarterial radioembolization.

Journal Article by Singal AG, Agopian VG (…) Yarchoan M et 17 al. in Hepatology

Copyright © 2026 The Author(s). Published by Wolters Kluwer Health, LLC.

read the whole article in Hepatology

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Ann Surg Oncol22 Oct 2026

Pancreatic cancer: occult spread in 1 in 4

In this prospective multicenter cohort, staging laparoscopy found occult metastases in 25% of imaging-M0 patients—including 20.6% with resectable disease—potentially sparing some patients a nonbeneficial resection.

J Gastrointest Surg21 Oct 2026

Primary closure after bile duct exploration: 0.4% leak

In this 743-patient single-center series, laparoscopic bile duct exploration achieved 95.6% stone clearance with a 0.4% bile-leak rate—reassuring results for surgeons considering T-tube-free closure.

All papers in HPB & Spleen →